- Effectiveness and safety of traditional Chinese medicine for... 2023-09-15
- Hypothesis that alpha-amylase evokes regulatory mechanisms o... 2023-09-15
- Risk factors of concurrent urinary sepsis in patients with d... 2023-09-15
- MicroRNA-155 mediates endogenous angiotensin II type 1 recep... 2023-09-15
- Recent therapeutic targets for the prevention and management... 2023-09-15
World Journal of Diabetes (WJD, World J Diabetes) is a high-quality, online, open-access, single-blind peer-reviewed journal published by the Baishideng Publishing Group. WJD accepts both solicited and unsolicited manuscripts. Articles published in WJD are high-quality, basic and clinical, influential research articles by established academic authors as well as new researchers. The paramount objective of WJD is to showcase and promote distinguished research in the field of diabetes, to help advance development of this field. The types of articles published in WJD include Editorial, Opinion Review, Frontier, Review, Minireview, Basic Study, Clinical Research, Systematic Review, Meta-analysis, Evidence-based Medicine, Field of Vision, Clinical Guidelines, Letter to the Editor, and Case Report. Submit here >>
- Lu Cai, MD, PhD, Professor, Pediatric Research Institute, University of Louisville, Louisville, KY 40202, United States
- Michael Horowitz, DSc, FRACP, MD, PhD, Professor, (E-mail: michael.horowitz@adelaide.edu.au) Department of Medicine, Royal Adelaide Hospital, Adelaide 5005, Australia
- Md. Shahidul Islam, BSc, MSc, PhD, Professor, Department of Biochemistry, University of KwaZulu-Natal, Durban 4000, South Africa
The 2023 Edition of Journal Citation Reports® cites the 2022 impact factor (IF) for WJD as 4.2; IF without journal self cites: 4.1; 5-year IF: 4.5; Journal Citation Indicator: 0.69; Ranking: 51 among 145 journals in endocrinology and metabolism; and Quartile category: Q2.







